Moreover, AR appears to exert different functions according to the BC subtype (9), e.g. in ER-positive BC AR may play an unfavorable prognostic role (13); in TNBC, AR could lead to a minor aggressive phenotype (14), but data from both clinical and preclinical trials are still controversial. Here, AR is linked to breast cancer.